We are live on ! Find out more
KURA icon

Kura Oncology
KURA

35 hedge funds and large institutions have $90.7M invested in Kura Oncology in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

225% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 4

56% more capital invested

Capital invested by funds: $58.2M → $90.7M (+$32.5M)

17% more funds holding

Funds holding: 30 → 35 (+5)

1.98% more ownership

Funds ownership: 46.22% → 48.2% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
35
Holders Change
+5
Holders Change %
+16.67%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
13
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.01M
2
Goldman Sachs
Goldman Sachs
New York
+$444K
3
PHS
PFM Health Sciences
California
+$402K
4
Renaissance Technologies
Renaissance Technologies
New York
+$356K
5
Millennium Management
Millennium Management
New York
+$296K

Top Sellers

Rank Fund Capital Flow
1
CCP
Clough Capital Partners
Massachusetts
-$1.17M
2
MA
Minerva Advisors
Pennsylvania
-$184K
3
PAM
Panagora Asset Management
Massachusetts
-$58K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$20.3K
5
RFA
Reilly Financial Advisors
California
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$24.8M – – –
EC
2
EcoR1 Capital
California
$23M – – –
PHS
3
PFM Health Sciences
California
$17.9M +$402K +54,800 +3%
BC
4
Boxer Capital
California
$4.69M – – –
CCP
5
Clough Capital Partners
Massachusetts
$4.41M -$1.17M -159,392 -24%
Morgan Stanley
6
Morgan Stanley
New York
$3.79M +$2.01M +274,166 +175%
Vanguard Group
7
Vanguard Group
Pennsylvania
$3.38M +$63.2K +8,619 +2%
MA
8
Minerva Advisors
Pennsylvania
$2.6M -$184K -25,100 -8%
BCM
9
Bridgeway Capital Management
Texas
$811K +$214K +29,200 +46%
ACM
10
Alethea Capital Management
Washington
$746K +$150K +20,469 +32%
Renaissance Technologies
11
Renaissance Technologies
New York
$697K +$356K +48,600 +159%
Goldman Sachs
12
Goldman Sachs
New York
$533K +$444K +60,530 New
Geode Capital Management
13
Geode Capital Management
Massachusetts
$437K +$3.12K +426 +0.9%
Millennium Management
14
Millennium Management
New York
$355K +$296K +40,382 New
BlackRock
15
BlackRock
New York
$343K +$286K +38,957 New
PPCM
16
Pillar Pacific Capital Management
California
$268K – – –
JMPWA
17
JP Morgan Private Wealth Advisors
California
$260K – – –
Deutsche Bank
18
Deutsche Bank
Germany
$219K +$120K +16,388 +192%
PIM
19
Partner Investment Management
California
$207K -$880 -120 -0.5%
California Public Employees Retirement System
20
California Public Employees Retirement System
California
$207K – – –
Squarepoint
21
Squarepoint
New York
$196K +$71.9K +9,800 +78%
NFA
22
Nationwide Fund Advisors
Ohio
$136K +$114K +15,500 New
Northern Trust
23
Northern Trust
Illinois
$125K +$13.3K +1,808 +15%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$125K +$104K +14,156 New
SCM
25
Segantii Capital Management
Hong Kong
$120K +$99.8K +13,614 New
1
2

KURA Hedge Fund Activity: Q1 2017 in Review

35 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q1 2017, worth a combined $90.7M — up 56% from $58.2M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new KURA positions and 3 closed out — a net gain of 7 holders — while 13 added to existing stakes and 4 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.01M. The largest seller was Clough Capital Partners, cutting an estimated $1.17M.

  • 35 institutional investors held Kura Oncology (KURA) as of Q1 2017, up from 30 in Q4 2016.
  • Funds reported $90.7M of Kura Oncology stock for Q1 2017, up 56% quarter-over-quarter.
  • 10 funds opened new Kura Oncology positions in Q1 2017 and 3 closed out, a net change of +7 holders.
  • The largest Kura Oncology buyer in Q1 2017 was Morgan Stanley, an estimated $2.01M added.
  • The largest Kura Oncology seller in Q1 2017 was Clough Capital Partners, an estimated $1.17M sold.

Based on aggregated 13F filings for Q1 2017.